2021
DOI: 10.21203/rs.3.rs-365468/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Communication Processes about Predictive Genetic Testing within High-Risk Breast Cancer Families: A Two-Phase Study Design

Abstract: Background: The detection of a pathogenic variant in the BRCA1 or BRCA2 gene has medical and psychological consequences for both, affected mutation carriers and their relatives. This study analyzed the psychological impact of genetic testing and mutation-positive test result as well as associated family communication processes from the perspective of BRCA1 or BRCA2 mutation carriers and their family members.Methods: We conducted a two-phase study with explanatory sequential mixed methods design to understand t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…Individual-level barriers include the perceived cost of genetic testing, knowledge and beliefs about the genetic testing process, fear related to being at an increased risk for cancer, fear of genetic discrimination, and distrust in the medical system (16)(17)(18). Additionally, patients may have confusion over different testing options (such as lab tests vs. direct-to-consumer genetic testing) (19).…”
Section: Barriers Presented By the Current Modelmentioning
confidence: 99%
See 1 more Smart Citation
“…Individual-level barriers include the perceived cost of genetic testing, knowledge and beliefs about the genetic testing process, fear related to being at an increased risk for cancer, fear of genetic discrimination, and distrust in the medical system (16)(17)(18). Additionally, patients may have confusion over different testing options (such as lab tests vs. direct-to-consumer genetic testing) (19).…”
Section: Barriers Presented By the Current Modelmentioning
confidence: 99%
“…Additionally, patients may have confusion over different testing options (such as lab tests vs. direct-to-consumer genetic testing) ( 19 ). These challenges make it difficult for patients to ascertain definitive answers related to medical genetic testing, leading to reduced genetic testing uptake ( 17 , 18 ).…”
Section: Barriers Presented By the Current Modelmentioning
confidence: 99%